Related Experiment Video
Updated: Aug 18, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Variations in initial assessment and management of inflammatory bowel disease across Great Britain and Ireland
A Sawczenko1, R Lynn, B K Sandhu
1Department of Gastroenterology, Bristol Children's Hospital, Bristol, UK.
Insights
Initial management of pediatric inflammatory bowel disease (IBD) in Great Britain and Ireland shows significant variation. Greater access to pediatric gastroenterology services is needed for optimized care in children with IBD.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease (IBD) Research
- Clinical Management Studies
Background:
- Lack of published data on initial management of pediatric inflammatory bowel disease (IBD) in Great Britain and Ireland.
- Need for comprehensive understanding of current diagnostic and treatment pathways for childhood IBD.
Purpose of the Study:
- To prospectively document the initial investigation and treatment of children under 16 with newly diagnosed IBD.
- To identify variations in care across different institutions and specialists.
Main Methods:
- Prospective survey of 3247 healthcare professionals across the UK and Ireland over 13 months.
- Monthly reporting of newly diagnosed childhood IBD cases, followed by detailed postal questionnaires.
Main Results:
- 739 new IBD cases reported from 172 institutions, revealing significant variations in investigation and treatment.
- Wide regional disparities in access to pediatric gastroenterology services; one-third of children received care from adult services.
- Children treated by adult services showed altered treatment patterns (e.g., increased steroid use, decreased dietary therapy) and less frequent recording of growth parameters.
Conclusions:
- Current specialist provision and initial management of pediatric IBD are heterogeneous.
- Optimizing care requires increased access to specialized pediatric gastroenterology services for all children with suspected IBD.
Background:
There are no published data from Great Britain and Ireland detailing the initial management of children with inflammatory bowel disease (IBD).
Aims:
To prospectively record the initial investigation and treatment of children aged less than 16 years with newly diagnosed IBD.
Methods:
For 13 months, between June 1998 and June 1999, 3247 paediatricians, adult gastroenterologists, and surgeons across the UK and Ireland were prospectively surveyed each month and asked to report every newly diagnosed case of childhood IBD. Reporters subsequently completed a postal questionnaire about each case.
Results:
A total of 739 new IBD cases were reported from 172 institutions. Significant variations were observed in the investigation and treatment of these cases, when examined by number of cases reported per institution, or by the specialists providing care. There were wide regional variations in the proportion of children having access to paediatric gastroenterology services. Overall, one third of children received care from an adult service, and a tenth care exclusively from an adult gastroenterologist. Children with Crohn's disease who had some or all of their care from adult services were more likely to receive systemic steroids and less likely to receive dietary therapy; those with ulcerative colitis were more likely to receive rectal steroids and to have surgery. Height and weight were also less likely to be recorded in those whose care involved adult services.
Conclusion:
Current specialist provision, and initial investigation and treatment of IBD, is heterogeneous. Optimisation of care is likely to be achieved by greater access to specialist paediatric gastroenterology services for all those with suspected IBD.
More Related Videos
09:44Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations